RxDoctor Payments Data

Ashley Baize, PA

Physician Assistant · Waco, TXNPI 1154061497

Payments from drug & device makers

$2,992in general payments, 2019–2025

Across 185 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$376
  • Astellas Pharma US Inc$243
  • Boehringer Ingelheim$234
  • Lilly USA, LLC$233
  • GSK$202
  • Pfizer$175
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$2,992100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,992 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$32,110
Medicare patients
172
Services billed
839

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$12,325
Duloxetine Hcl24$806
Gabapentin29$749
Albuterol Sulfate HfaAlbuterol Sulfate24$720
Fluticasone Propionate23$411
Diclofenac Sodium20$410
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst21$363
Omeprazole14$354
Pregabalin21$274
Rosuvastatin Calcium21$260
Levothyroxine Sodium25$227
Clindamycin Phosphate13$223
Losartan Potassium21$218
Amlodipine Besylate27$211
Cefdinir13$176

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$202$12,32511 claims
PfizerPaxlovid$175$018 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Waco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →